- $75.62bn
- $93.82bn
- $14.09bn
- 88
- 31
- 59
- 63
Annual income statement for CSX, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | R2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 52 W | 52 W | 52 W | 52 W | 52 W |
| Source: | 10-K | 10-K | 10-K | 10-K | 8-K |
| Standards: | USG | USG | USG | USG | — |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 12,522 | 14,853 | 14,657 | 14,540 | 14,092 |
| Cost of Revenue | |||||
| Gross Profit | 9,474 | 10,542 | 10,478 | 10,520 | 9,984 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 6,928 | 8,830 | 9,158 | 9,295 | 9,571 |
| Operating Profit | 5,594 | 6,023 | 5,499 | 5,245 | 4,521 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 4,951 | 5,414 | 4,829 | 4,555 | 3,769 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 3,781 | 4,166 | 3,668 | 3,470 | 2,889 |
| Net Income Before Extraordinary Items | |||||
| Net Income | 3,781 | 4,166 | 3,668 | 3,470 | 2,889 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 3,781 | 4,166 | 3,668 | 3,470 | 2,889 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 1.52 | 1.87 | 1.81 | 1.82 | 1.61 |
| Dividends per Share |